Sign in

CIK 0001782303 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Boundless Bio, Inc.

Sign in to watch
Ticker
BOLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
830751369
Phone
(858) 766-9912
Business address
11099 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA, 92037
  1. 4 Open-market buy 10% owner bought 4,863 shares at $2.44 ($11,866)
  2. 4 Open-market buy 10% owner bought 63,969 shares at an average $2.43 ($155,646)
  3. 4 Open-market buy 10% owner bought 91,585 shares at an average $2.42 ($222,070)
  4. 4 Open-market buy 10% owner bought 57,210 shares at an average $2.48 ($141,865)
  5. 4 Open-market sale 10% owner sold 16,000 shares at $2.49 ($39,840)
  6. 4 Open-market sale 10% owner sold 16,000 shares at $2.49 ($39,840)
  7. 4 Open-market buy 10% owner bought 107,463 shares at an average $2.50 ($268,880)
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Open-market buy 10% owner bought 286,333 shares at an average $2.50 ($714,768)
  10. 3 Insider Initial Statement of Ownership
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 8-K Event Material agreement · Exit or restructuring costs · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure · Other events
  13. 8-K Event Shareholder vote results
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. ARS Other Annual Report to Security Holders

Page 2 of 9 · 164 filings